JP7264808B2 - 注射可能なフォームを生成するための方法およびデバイス - Google Patents
注射可能なフォームを生成するための方法およびデバイス Download PDFInfo
- Publication number
- JP7264808B2 JP7264808B2 JP2019502084A JP2019502084A JP7264808B2 JP 7264808 B2 JP7264808 B2 JP 7264808B2 JP 2019502084 A JP2019502084 A JP 2019502084A JP 2019502084 A JP2019502084 A JP 2019502084A JP 7264808 B2 JP7264808 B2 JP 7264808B2
- Authority
- JP
- Japan
- Prior art keywords
- foam
- gas
- liquid
- pump
- pathway
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229940076549 injectable foam Drugs 0.000 title claims description 5
- 238000000034 method Methods 0.000 title description 24
- 239000006260 foam Substances 0.000 claims description 256
- 239000007789 gas Substances 0.000 claims description 230
- 239000007788 liquid Substances 0.000 claims description 187
- 230000037361 pathway Effects 0.000 claims description 40
- 238000004891 communication Methods 0.000 claims description 22
- 239000002699 waste material Substances 0.000 claims description 22
- 238000006073 displacement reaction Methods 0.000 claims description 14
- 230000003750 conditioning effect Effects 0.000 claims description 7
- 238000009826 distribution Methods 0.000 claims description 6
- 239000003814 drug Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 229920001363 Polidocanol Polymers 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 7
- ONJQDTZCDSESIW-UHFFFAOYSA-N polidocanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO ONJQDTZCDSESIW-UHFFFAOYSA-N 0.000 description 7
- 229960002226 polidocanol Drugs 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 230000002572 peristaltic effect Effects 0.000 description 6
- 206010046996 Varicose vein Diseases 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 229940124597 therapeutic agent Drugs 0.000 description 5
- 208000027185 varicose disease Diseases 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000001569 carbon dioxide Substances 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 239000003229 sclerosing agent Substances 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010001526 Air embolism Diseases 0.000 description 2
- 241000239290 Araneae Species 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 229940121357 antivirals Drugs 0.000 description 2
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 239000003246 corticosteroid Substances 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000004848 polyfunctional curative Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000007632 sclerotherapy Methods 0.000 description 2
- 229960000776 sodium tetradecyl sulfate Drugs 0.000 description 2
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 2
- 238000007910 systemic administration Methods 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 208000037997 venous disease Diseases 0.000 description 2
- 201000009371 venous hemangioma Diseases 0.000 description 2
- -1 xenone Substances 0.000 description 2
- 201000000628 Gas Gangrene Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010019695 Hepatic neoplasm Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- 208000010195 Onychomycosis Diseases 0.000 description 1
- 206010034240 Pelvic congestion Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 208000013868 Taylor syndrome Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 229940037157 anticorticosteroids Drugs 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 238000005381 potential energy Methods 0.000 description 1
- 229940071643 prefilled syringe Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000003752 saphenous vein Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- IMCGHZIGRANKHV-AJNGGQMLSA-N tert-butyl (3s,5s)-2-oxo-5-[(2s,4s)-5-oxo-4-propan-2-yloxolan-2-yl]-3-propan-2-ylpyrrolidine-1-carboxylate Chemical compound O1C(=O)[C@H](C(C)C)C[C@H]1[C@H]1N(C(=O)OC(C)(C)C)C(=O)[C@H](C(C)C)C1 IMCGHZIGRANKHV-AJNGGQMLSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000005882 tinea unguium Diseases 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/12186—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices liquid materials adapted to be injected
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00491—Surgical glue applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/12031—Type of occlusion complete occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0036—Porous materials, e.g. foams or sponges
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/20—Mixing gases with liquids
- B01F23/23—Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids
- B01F23/235—Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids for making foam
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/45—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/20—Measuring; Control or regulation
- B01F35/21—Measuring
- B01F35/211—Measuring of the operational parameters
- B01F35/2111—Flow rate
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/71—Feed mechanisms
- B01F35/717—Feed mechanisms characterised by the means for feeding the components to the mixer
- B01F35/7176—Feed mechanisms characterised by the means for feeding the components to the mixer using pumps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/80—Forming a predetermined ratio of the substances to be mixed
- B01F35/83—Forming a predetermined ratio of the substances to be mixed by controlling the ratio of two or more flows, e.g. using flow sensing or flow controlling devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/80—Forming a predetermined ratio of the substances to be mixed
- B01F35/83—Forming a predetermined ratio of the substances to be mixed by controlling the ratio of two or more flows, e.g. using flow sensing or flow controlling devices
- B01F35/831—Forming a predetermined ratio of the substances to be mixed by controlling the ratio of two or more flows, e.g. using flow sensing or flow controlling devices using one or more pump or other dispensing mechanisms for feeding the flows in predetermined proportion, e.g. one of the pumps being driven by one of the flows
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C44/00—Shaping by internal pressure generated in the material, e.g. swelling or foaming ; Producing porous or cellular expanded plastics articles
- B29C44/34—Auxiliary operations
- B29C44/60—Measuring, controlling or regulating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00526—Methods of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00893—Material properties pharmaceutically effective
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M5/2053—Media being expelled from injector by pressurised fluid or vacuum
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C44/00—Shaping by internal pressure generated in the material, e.g. swelling or foaming ; Producing porous or cellular expanded plastics articles
- B29C44/02—Shaping by internal pressure generated in the material, e.g. swelling or foaming ; Producing porous or cellular expanded plastics articles for articles of definite length, i.e. discrete articles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/04—Condition, form or state of moulded material or of the material to be shaped cellular or porous
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/753—Medical equipment; Accessories therefor
- B29L2031/7532—Artificial members, protheses
- B29L2031/7534—Cardiovascular protheses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Description
図1Aおよび1Bは、本発明の主要構成要素の概略図を示し、フォームを生成する構造(4)は液体および気体のための入口(5)ならびにフォームのための出口(6)を有して示されている。液体経路(1)は入口(5)と連通し、気体経路(2)は別個の入口(5)と連通する。ポンプ(3)は液体経路(1)内に提供される。
Claims (21)
- 注射可能なフォームを生成するためのデバイスであって、
その中でフォームを生成するために液体と気体が組み合わされるフォームを生成する構造であって、前記構造は液体および気体のための入口ならびにフォームのための出口を備える、フォームを生成する構造と、
前記入口と連通する液体経路と、
前記入口と連通する気体経路と
を備え、
前記液体経路は、前記気体経路を通る気体の送達と無関係に、前記液体経路を通って液体を送達するための手段を備え、
前記デバイスは、制御ユニットをさらに備え、
前記制御ユニットが、前記フォームを生成する構造に供給される前記液体および気体の相対量および流量を調整して、所望の密度を含む前記注射可能なフォームの少なくとも1つの特性を制御し、
前記デバイスは少なくとも前記所望の密度を有する前記注射可能なフォームを生成する、デバイス。 - 前記液体経路の中に液体を導入するように配置された発泡性液体源をさらに備える、請求項1に記載のデバイス。
- 前記発泡性液体源は密封容器である、請求項2に記載のデバイス。
- 前記液体経路を通って液体を送達するための前記手段はポンプである、請求項1に記載のデバイス。
- 前記ポンプは容積式ポンプである、請求項4に記載のデバイス。
- 前記ポンプを駆動するように配置されたモータをさらに備える、請求項4に記載のデバイス。
- 前記液体経路は一方向弁または背圧弁を備える、請求項1に記載のデバイス。
- 前記気体経路の中に気体を導入するように配置された気体源をさらに備える、請求項1に記載のデバイス。
- 前記気体源は圧縮ガスシリンダである、請求項8に記載のデバイス。
- 前記気体経路はガス圧力調整器を備える、請求項9に記載のデバイス。
- 前記気体経路は弁を備える、請求項9に記載のデバイス。
- 前記気体経路はポンプを備える、請求項1に記載のデバイス。
- 前記ポンプは容積式ポンプである、請求項12に記載のデバイス。
- 前記ポンプを駆動するように配置されたモータをさらに備える、請求項12に記載のデバイス。
- 前記気体経路は気体を滅菌するフィルタを備える、請求項1に記載のデバイス。
- フォーム経路により前記出口に連結されたフォームポートをさらに備える、請求項1に記載のデバイス。
- 前記フォーム経路はフォームを調整する構造を備える、請求項16に記載のデバイス。
- 廃棄チャンバをさらに備える、請求項16に記載のデバイス。
- 使い捨てカートリッジ、消耗品またはカセットの形である、請求項1に記載のデバイス。
- 前記制御ユニットはCPUを備える、請求項1に記載のデバイス。
- 前記フォーム経路内の泡の大きさの分配を測定するように構成された泡寸法測定器をさらに備える、請求項16に記載のデバイス。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1612925.6 | 2016-07-26 | ||
GBGB1612925.6A GB201612925D0 (en) | 2016-07-26 | 2016-07-26 | Method and device for generating injectable foam |
PCT/IB2017/054537 WO2018020436A1 (en) | 2016-07-26 | 2017-07-26 | Method and device for generating injectable foam |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2019527100A JP2019527100A (ja) | 2019-09-26 |
JPWO2018020436A5 JPWO2018020436A5 (ja) | 2022-08-17 |
JP7264808B2 true JP7264808B2 (ja) | 2023-04-25 |
Family
ID=56894428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019502084A Active JP7264808B2 (ja) | 2016-07-26 | 2017-07-26 | 注射可能なフォームを生成するための方法およびデバイス |
Country Status (9)
Country | Link |
---|---|
US (2) | US11819218B2 (ja) |
EP (1) | EP3490463A1 (ja) |
JP (1) | JP7264808B2 (ja) |
KR (2) | KR20190035679A (ja) |
CN (1) | CN109414258B (ja) |
CA (1) | CA3029769A1 (ja) |
GB (2) | GB201612925D0 (ja) |
SG (1) | SG11201811082SA (ja) |
WO (1) | WO2018020436A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201800006109A1 (it) | 2018-06-07 | 2019-12-07 | Polidocanolo per uso come immunomodulatore | |
US11517527B2 (en) * | 2018-11-05 | 2022-12-06 | Ethicon, Inc. | Systems, devices and methods for making and expressing foam used in medical procedures |
EP4021533A1 (en) * | 2019-08-26 | 2022-07-06 | Solstice Pharmaceuticals B.V. | A cartridge for mixing a liquid intended for intracorporeal use |
CN115791540A (zh) * | 2021-09-09 | 2023-03-14 | 泰连服务有限公司 | 气泡测量系统和方法 |
US11995860B2 (en) * | 2022-01-04 | 2024-05-28 | Te Connectivity Solutions Gmbh | Bubble measurement system and method |
US12005404B2 (en) * | 2022-08-22 | 2024-06-11 | Sharkninja Operating Llc | Beverage carbonation system flow control |
CN116001179A (zh) * | 2022-12-20 | 2023-04-25 | 北京城乡建设集团有限责任公司 | 一种灌注发泡装置及其使用方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008517760A (ja) | 2004-10-29 | 2008-05-29 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 超音波造影剤の製造装置及び方法 |
JP2010512899A (ja) | 2006-12-21 | 2010-04-30 | ビーティージー・インターナショナル・リミテッド | 治療用フォームを生産するための装置および方法 |
JP2011136192A (ja) | 2003-09-10 | 2011-07-14 | Btg Internatl Ltd | 泡を分配するための方法 |
JP2013524937A (ja) | 2010-04-30 | 2013-06-20 | エイチ アール ディー コーポレーション | 薬物療法における高せん断の利用 |
US20160166782A1 (en) | 2006-11-27 | 2016-06-16 | Frank Levy | Apparatus and method for producing co2 enriched medical foam |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2214453B1 (ja) * | 1973-01-24 | 1976-05-14 | Medicoplast Labor | |
JPS5227033Y2 (ja) * | 1974-05-20 | 1977-06-20 | ||
SU546350A1 (ru) * | 1975-11-28 | 1977-02-15 | Предприятие П/Я В-2775 | Установка дл получени кислородного коктейл |
GB1589306A (en) | 1978-05-24 | 1981-05-13 | Grace W R Ltd | Method and apparatus for mixing polyurethane foam |
SU936915A1 (ru) * | 1980-05-30 | 1982-06-23 | Львовский Научно-Исследовательский Институт Туберкулеза | Устройство дл приготовлени лечебной пены |
US4474680A (en) * | 1983-03-14 | 1984-10-02 | Valerin Technologies Limited | Foam generating apparatus and method |
US4769241A (en) * | 1986-09-23 | 1988-09-06 | Alpha Therapeutic Corporation | Apparatus and process for oxygenation of liquid state dissolved oxygen-carrying formulation |
EP0529902B1 (en) * | 1991-08-21 | 1999-02-10 | Smith & Nephew, Inc. | Fluid management system |
ES2068151B1 (es) * | 1993-06-23 | 1995-11-16 | Cabrera Garrido Juan | Microespuma inyectable para esclerosis. |
EP0808575B1 (fr) * | 1996-05-21 | 2002-04-10 | Societe Des Produits Nestle S.A. | Produit concentré congelé à base de lait et procedé de fabrication |
WO1999049959A1 (en) | 1998-03-30 | 1999-10-07 | Pavel Nikolaevich Kadushin | Method for producing foam and device for realising the same |
ES1043183Y (es) * | 1999-05-03 | 2000-04-01 | Mingo Fco Javier Garcia | Dispositivo para producir esclerosante espumado. |
GB9912356D0 (en) * | 1999-05-26 | 1999-07-28 | Btg Int Ltd | Generation of microfoam |
GB0028692D0 (en) * | 2000-11-24 | 2001-01-10 | Btg Int Ltd | Generation of therapeutic microform |
GB2369996B (en) * | 2000-12-18 | 2004-06-23 | S T D Pharmaceutical Products | Method and apparatus for producing an injectable foam |
US9440046B2 (en) * | 2002-04-04 | 2016-09-13 | Angiodynamics, Inc. | Venous insufficiency treatment method |
CA2546227A1 (en) * | 2003-11-17 | 2005-06-02 | Btg International Limited | Methods of preparing a foam comprising a sclerosing agent |
GB0326768D0 (en) * | 2003-11-17 | 2003-12-24 | Btg Int Ltd | Generation of therapeutic microfoam |
GB0327957D0 (en) | 2003-12-03 | 2004-01-07 | Btg Int Ltd | Apparatus for delivering foam |
US7809180B2 (en) | 2004-07-05 | 2010-10-05 | Panasonic Corporation | Method of generating image of component |
US8257338B2 (en) | 2006-10-27 | 2012-09-04 | Artenga, Inc. | Medical microbubble generation |
FR2903594B1 (fr) * | 2006-07-13 | 2008-09-19 | I2M Sarl | Dispositif de production d'une mousse injectable. |
US7967834B2 (en) * | 2006-09-13 | 2011-06-28 | Vascular Insights Llc | Vascular treatment device |
JP2014508571A (ja) * | 2011-01-11 | 2014-04-10 | アムセル・メディカル・コーポレーション | 静脈瘤を治療するための方法および装置 |
US20130037277A1 (en) | 2011-08-12 | 2013-02-14 | Darren Sean Henry | Foam Generating Apparatus |
US9480867B2 (en) * | 2011-11-11 | 2016-11-01 | Waterous Company | Proportional dynamic ratio control for compressed air foam delivery |
JP2013202201A (ja) | 2012-03-28 | 2013-10-07 | Terumo Corp | 医療用長尺体 |
EP3069680B1 (de) * | 2012-10-25 | 2019-04-03 | W & H Dentalwerk Bürmoos GmbH | Verfahren zur steuerung einer mit druckgas betreibbaren medizinischen antriebsvorrichtung und derartige antriebsvorrichtung |
US20140316012A1 (en) * | 2013-03-15 | 2014-10-23 | Toby Freyman | In-Situ Forming Foams for Embolizing or Occluding a Cavity |
CN203724465U (zh) * | 2013-10-14 | 2014-07-23 | 胡新彦 | 一次性配药连接器 |
WO2015162499A2 (en) | 2014-03-31 | 2015-10-29 | Piotrovski Murillo Caporal | Rechargeable and resterilizable mixing device with physiological gas and solution to create foam with microbubbles, used in endovascular treatments |
US20150283523A1 (en) * | 2014-04-03 | 2015-10-08 | Waterous Company | Compressed air foam generation |
US10058825B2 (en) * | 2014-12-12 | 2018-08-28 | Nordson Corporation | Foam mixing system and methods |
-
2016
- 2016-07-26 GB GBGB1612925.6A patent/GB201612925D0/en not_active Ceased
-
2017
- 2017-07-26 CN CN201780040064.6A patent/CN109414258B/zh active Active
- 2017-07-26 EP EP17758286.3A patent/EP3490463A1/en active Pending
- 2017-07-26 CA CA3029769A patent/CA3029769A1/en active Pending
- 2017-07-26 KR KR1020197000688A patent/KR20190035679A/ko not_active IP Right Cessation
- 2017-07-26 GB GB1712009.8A patent/GB2555179A/en not_active Withdrawn
- 2017-07-26 US US16/320,591 patent/US11819218B2/en active Active
- 2017-07-26 JP JP2019502084A patent/JP7264808B2/ja active Active
- 2017-07-26 SG SG11201811082SA patent/SG11201811082SA/en unknown
- 2017-07-26 KR KR1020237033632A patent/KR102686994B1/ko active IP Right Grant
- 2017-07-26 WO PCT/IB2017/054537 patent/WO2018020436A1/en unknown
-
2023
- 2023-10-16 US US18/380,317 patent/US20240032942A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011136192A (ja) | 2003-09-10 | 2011-07-14 | Btg Internatl Ltd | 泡を分配するための方法 |
JP2008517760A (ja) | 2004-10-29 | 2008-05-29 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 超音波造影剤の製造装置及び方法 |
US20160166782A1 (en) | 2006-11-27 | 2016-06-16 | Frank Levy | Apparatus and method for producing co2 enriched medical foam |
JP2010512899A (ja) | 2006-12-21 | 2010-04-30 | ビーティージー・インターナショナル・リミテッド | 治療用フォームを生産するための装置および方法 |
JP2013524937A (ja) | 2010-04-30 | 2013-06-20 | エイチ アール ディー コーポレーション | 薬物療法における高せん断の利用 |
Also Published As
Publication number | Publication date |
---|---|
CN109414258B (zh) | 2022-06-07 |
GB201712009D0 (en) | 2017-09-06 |
KR20230142660A (ko) | 2023-10-11 |
US20240032942A1 (en) | 2024-02-01 |
US20190159786A1 (en) | 2019-05-30 |
GB201612925D0 (en) | 2016-09-07 |
CA3029769A1 (en) | 2018-02-01 |
KR20190035679A (ko) | 2019-04-03 |
US11819218B2 (en) | 2023-11-21 |
GB2555179A (en) | 2018-04-25 |
WO2018020436A1 (en) | 2018-02-01 |
KR102686994B1 (ko) | 2024-07-19 |
JP2019527100A (ja) | 2019-09-26 |
CN109414258A (zh) | 2019-03-01 |
EP3490463A1 (en) | 2019-06-05 |
SG11201811082SA (en) | 2019-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7264808B2 (ja) | 注射可能なフォームを生成するための方法およびデバイス | |
US10532835B2 (en) | Automated reservoir fill system | |
JP4988353B2 (ja) | 治療用フォーム | |
US8517975B2 (en) | Device and method for producing therapeutic foam | |
TW201124179A (en) | Tubing set having a gate for the connection of vials | |
JP7450608B2 (ja) | 流体注入器システム、流体の逆流を防止する方法、およびコンピュータプログラム製品 | |
US10368873B2 (en) | Method and device for producing foam | |
JPWO2018020436A5 (ja) | ||
CA2686698A1 (en) | Rapid injection manifold |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20200409 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20200416 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200722 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210623 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210706 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211006 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220308 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220607 |
|
A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20220805 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221220 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230308 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230328 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230413 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7264808 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S631 | Written request for registration of reclamation of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313631 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |